Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder

[1] Bowden CL(2005)Valproate in bipolar disorder: 2000 onwards Acta Psychiatr Scand 111 13-20

[2] Singh V(2011)Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care World Psychiatry 10 52-77

[3] De Hert M(2010)The role of valproate in metabolic disturbances in bipolar disorder patients J Affect Disord 124 319-323

[4] Correll CU(2015)Valproic acid as a potentiator of metabolic syndrome in institutionalized residents on concomitant antipsychotics: fat chance, or slim to none? PT 40 126-132

[5] Bobes J(2015)Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis World Psychiatry 14 339-347

[6] Chang HH(2015)Management of adverse effects of mood stabilizers Curr Psychiatry Rep 17 66-76

[7] Yang YK(2013)Adverse drug reactions induced by valproic acid Clin Biochem 46 1323-1338

[8] Gean PW(2013)Psychotropic-induced weight gain: a review of management strategies Consultant 53 153-160

[9] Huang HC(2012)Obesity and psychotropics CNS Neurosci Ther 18 57-63

[10] Chen PS(2014)Role of adverse effects in medication nonadherence in bipolar disorder Harv Rev Psychiatry 22 363-366

[1] Bowden CL(2005)Valproate in bipolar disorder: 2000 onwards Acta Psychiatr Scand 111 13-20

[2] Singh V(2011)Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care World Psychiatry 10 52-77

[3] De Hert M(2010)The role of valproate in metabolic disturbances in bipolar disorder patients J Affect Disord 124 319-323

[4] Correll CU(2015)Valproic acid as a potentiator of metabolic syndrome in institutionalized residents on concomitant antipsychotics: fat chance, or slim to none? PT 40 126-132

[5] Bobes J(2015)Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis World Psychiatry 14 339-347

[6] Chang HH(2015)Management of adverse effects of mood stabilizers Curr Psychiatry Rep 17 66-76

[7] Yang YK(2013)Adverse drug reactions induced by valproic acid Clin Biochem 46 1323-1338

[8] Gean PW(2013)Psychotropic-induced weight gain: a review of management strategies Consultant 53 153-160

[9] Huang HC(2012)Obesity and psychotropics CNS Neurosci Ther 18 57-63

[10] Chen PS(2014)Role of adverse effects in medication nonadherence in bipolar disorder Harv Rev Psychiatry 22 363-366